BIOVF Statistics
Total Valuation
BIOVF has a market cap or net worth of 9.88 billion. The enterprise value is 11.11 billion.
| Market Cap | 9.88B |
| Enterprise Value | 11.11B |
Important Dates
The next estimated earnings date is Thursday, October 23, 2025.
| Earnings Date | Oct 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 344.61M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.64% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 220.67M |
Valuation Ratios
The trailing PE ratio is 21.49 and the forward PE ratio is 17.84.
| PE Ratio | 21.49 |
| Forward PE | 17.84 |
| PS Ratio | 3.48 |
| PB Ratio | 2.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.49 |
| P/OCF Ratio | 14.36 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.61, with an EV/FCF ratio of 16.30.
| EV / Earnings | 24.17 |
| EV / Sales | 3.93 |
| EV / EBITDA | 10.61 |
| EV / EBIT | 16.55 |
| EV / FCF | 16.30 |
Financial Position
The company has a current ratio of 1.00, with a Debt / Equity ratio of 0.33.
| Current Ratio | 1.00 |
| Quick Ratio | 0.66 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 1.28 |
| Debt / FCF | 1.98 |
| Interest Coverage | 6.11 |
Financial Efficiency
Return on equity (ROE) is 11.57% and return on invested capital (ROIC) is 7.61%.
| Return on Equity (ROE) | 11.57% |
| Return on Assets (ROA) | 5.65% |
| Return on Invested Capital (ROIC) | 7.61% |
| Return on Capital Employed (ROCE) | 11.35% |
| Revenue Per Employee | 1.46M |
| Profits Per Employee | 237,355 |
| Employee Count | 1,806 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 1.45 |
Taxes
In the past 12 months, BIOVF has paid 71.09 million in taxes.
| Income Tax | 71.09M |
| Effective Tax Rate | 13.41% |
Stock Price Statistics
The stock price has increased by +20.33% in the last 52 weeks. The beta is 0.26, so BIOVF's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | +20.33% |
| 50-Day Moving Average | 28.34 |
| 200-Day Moving Average | 23.36 |
| Relative Strength Index (RSI) | 50.65 |
| Average Volume (20 Days) | 610 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIOVF had revenue of 2.84 billion and earned 459.76 million in profits. Earnings per share was 1.33.
| Revenue | 2.84B |
| Gross Profit | 2.23B |
| Operating Income | 674.07M |
| Pretax Income | 530.00M |
| Net Income | 459.76M |
| EBITDA | 1.04B |
| EBIT | 674.07M |
| Earnings Per Share (EPS) | 1.33 |
Balance Sheet
The company has 111.26 million in cash and 1.35 billion in debt, giving a net cash position of -1.24 billion.
| Cash & Cash Equivalents | 111.26M |
| Total Debt | 1.35B |
| Net Cash | -1.24B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.11B |
| Book Value Per Share | 11.92 |
| Working Capital | 2.84M |
Cash Flow
In the last 12 months, operating cash flow was 688.27 million and capital expenditures -6.41 million, giving a free cash flow of 681.85 million.
| Operating Cash Flow | 688.27M |
| Capital Expenditures | -6.41M |
| Free Cash Flow | 681.85M |
| FCF Per Share | n/a |
Margins
Gross margin is 78.45%, with operating and profit margins of 23.77% and 16.21%.
| Gross Margin | 78.45% |
| Operating Margin | 23.77% |
| Pretax Margin | 18.69% |
| Profit Margin | 16.21% |
| EBITDA Margin | 36.60% |
| EBIT Margin | 23.77% |
| FCF Margin | 24.04% |
Dividends & Yields
BIOVF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.64% |
| Shareholder Yield | n/a |
| Earnings Yield | 4.65% |
| FCF Yield | 6.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIOVF has an Altman Z-Score of 3.28 and a Piotroski F-Score of 8.
| Altman Z-Score | 3.28 |
| Piotroski F-Score | 8 |